Clinical Trials Browser

Phase 1/2 × Ga(III)-DOTATOC × 90 days × Clear all

NCT07150806 2025-12-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Phase 1/2 Recruiting

Meningioma